Fig. 2From: Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohortAnalysis of one-year Overall Survival (A) and Progression-Free Survival (B) in patients admitted and not admitted to the ICU. ICU Intensive care unit. 2A: Shown are Kaplan–Meier estimates of overall survival among the patients admitted and not admitted to the ICU. 2B: Shown are Kaplan–Meier estimates of progression-free survival among the ICU survivors and the patients not admitted to the ICUBack to article page